Computerized nuclear morphometry and survival in renal cell carcinoma: Comparison with other prognostic indicators

REFERENCES

• Mostofi FK. Pathology and the spread of renal cell carcinoma. Little Brown, Boston 1967
   Google Scholar
• Baak JPA. The principles and advances of quantitative pathology. Anal Quant Cyto Pathol 1987; 9: 89–95
   PubMed Web of Science ®Google Scholar
• Fleege JC, Baak JPA, Smeulders AWM. Analysis of measuring system parameters that influence reproducibility of morphometric assessments with a graphic tablet. Hum Pathol 1988; 19: 513–517
   PubMed Web of Science ®Google Scholar
• Neilsen K, Ostri P. Stereological estimate of nuclear volume in the course of primary tumors of the renal pelvis. Proceedings of the 17th International Congress of the International Academy. 1988; 334–334
   Google Scholar
• Blomjous, CEM, Vos, W, Schipper, NW, et al. The prognostic significance of selective nuclear morphometry in urinary bladder carcinoma. Hum Pathol 1990; 21: 409–413
   PubMed Web of Science ®Google Scholar
• Partin, AW, Walsh, AC, Epstein, JI, et al. Nuclear morphometry as a predictor of response to therapy in Wilms' tumor: a preliminary report. J Urol 1990; 114: 952–954
   Web of Science ®Google Scholar
• Partin, AW, Gearhart, JP, Leonard, MP, et al. The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a review. Med Pediatr Oncol 1993; 21: 222–229
   PubMedGoogle Scholar
• Feulgen R, Rossenbeck H. Mikroskopisch-chemischer nachweis einer nucleinsaure von typus der thymonucleinsaure und auf die darauf beruhende elektive farbung von zellkernen in mikroskopischen praparaten. Z Physiol Chem 1924; 135: 203–248
   Google Scholar
• Cox DR. Regression models and life tables. J Roy Stat Soc B 1972; 34: 187–220
   Web of Science ®Google Scholar
• Delahunt B, Nacey JN. Renal cell carcinoma II. Histological indicators of prognosis. Pathology 1987; 19: 258–263
   PubMed Web of Science ®Google Scholar
• Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101: 297–301
   PubMed Web of Science ®Google Scholar
• Crocker J, Nar P. Nucleolar organizer regions in lymphomas. J Pathol 1987; 151: 111–118
   PubMed Web of Science ®Google Scholar
• Delahunt, B, Bethwaite, PB, Nacey, JN, et al. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index and silverstaining nucleolar organizer region numbers. J Pathol 1993; 170: 471–477
   PubMed Web of Science ®Google Scholar
• Delahunt, B, Ribas, JL, Nacey, JN, et al. Nucleolar organizer regions and prognosis in renal cell carcinoma. J Pathol 1991; 163: 31–37
   PubMed Web of Science ®Google Scholar
• Kaplan EC, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1952; 53: 457–481
   Google Scholar
• Skinner DG, Colvin RB, Vermillion CD. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 1971; 28: 1165–1177
   PubMed Web of Science ®Google Scholar
• Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655–663
   PubMed Web of Science ®Google Scholar
• Medeiros LJ, Gelb AB, Weiss LM. Renal cell carcinoma. Prognostic significance of morphologic parameters in 121 cases. Cancer 1988; 61: 1639–1651
   PubMed Web of Science ®Google Scholar
• Helpap B, Knupffer J, Essman S. Histologisches und zytologisches (nukleolares) grading von nierenzellkarzinomen. Verh Dtsch Ges Path 1989; 73: 400–404
   PubMedGoogle Scholar
• Storkel, S, Thoenes, W, Jacobi, GH, et al. Prognostic parameters in renal cell carcinoma — a new approach. Eur Urol 1989; 16: 416–422
   PubMed Web of Science ®Google Scholar
• Gilchrist KW, Hogan TF, Harberg J. Simplified nuclear assessment as a prognostic discriminant in renal cell carcinoma. Lab Invest 1981; 44: 23A–23A
   Web of Science ®Google Scholar
• Gilchrist, KW, Hogan, TF, Harberg, J, et al. Prognostic significance of nuclear sizing in renal cell carcinoma. Urology 1984; 24: 122–124
   PubMed Web of Science ®Google Scholar
• Tosi, P, Luzi, P, Baak, JPA, et al. Nuclear morphometry as an important prognostic factor in stage I renal cell carcinoma. Cancer 1986; 58: 2512–2518
   PubMed Web of Science ®Google Scholar
• Donhuijsen K, Schulz S, Leder L-D. Nuclear grading of renal cell carcinomas — is morphometry necessary?. J Cancer Res Clin Oncol 1991; 117: 73–78
   PubMed Web of Science ®Google Scholar
• Gonzalez-Campora, R, de Chaves, FJG, Mora-Marin, J, et al. Nuclear planimetry in renal-cell tumors. Anal Quant Cytol Histol 1991; 13: 54–60
   PubMed Web of Science ®Google Scholar
• Gutierrez, JL, Buelta, L, Val-Bernal, JF, et al. Nuclear morphometry in prognosis of renal adenocarcinoma. Urology 1992; 39: 130–134
   PubMed Web of Science ®Google Scholar
• Murphy, GF, Partin, AW, Maygarden, SJ, et al. Nuclear shape analysis for assessment of prognosis in renal cell carcinoma. J Urol 1990; 143: 1103–1107
   PubMed Web of Science ®Google Scholar
• Bibbo, M, Galera-Davidson, H, Dytch, HE, et al. Karyometry and histometry of renal cell carcinoma. Anal Quant Cytol Histol 1987; 9: 182–187
   PubMed Web of Science ®Google Scholar
• Pound, CR, Partin, AW, Epstein, JI, et al. Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma. Urology 1993; 42: 243–248
   PubMed Web of Science ®Google Scholar